October is Breast Cancer Awareness Month, a time to highlight the importance of early detection and treatment for breast cancer. In 2024, over 360,000 individuals in the U.S. will be diagnosed, making awareness and education crucial. Key Breast Cancer Facts*: The Importance of Early Detection Early detection can lead to a 99% survival rate**. A …
By Sumedha ShastryHave you ever been watching TV and stumbled upon an advertisement promoting an 80s aerobics class—filled with bright workout outfits and groovy background music? For many, it brings back memories of decades past, when Jane Fonda and Arnold Schwarzenegger were iconic television figures; for others, like me, it exposes life before YouTube workout …
The Foundation for Peripheral Neuropathy (FPN) is pleased to announce the 2024 Clinical Research Training Scholarship (CRTS) recipient for peripheral neuropathy (PN), Francesco E. Michelassi, MD, PhD, Neuromuscular Research Fellow, Columbia University Irving Medical Center. Michelassi’s research is fully funded by FPN and will focus on chemotherapy-induced peripheral neuropathy (CIPN), by studying how a chemotherapy …
Clinical Research Training Scholarship Recipient Announced Read More »
My name is Sumedha, and I am a current high school senior in Maryland. Though I do not have peripheral neuropathy (PN) and do not know of anyone in my personal life who does, I am driven by a desire to understand and helping PN patients directly with this debilitating condition, using my research experience …
The Foundation for Peripheral Neuropathy (FPN) is delighted to announce that Sandra Rieger, PhD, has joined the Foundation’s Scientific Advisory Board (SAB). The SAB advises both the Board of Directors and staff of the Foundation in areas of science and technology relevant to peripheral neuropathy and its research. Dr. Sandra Rieger earned a Ph.D. in Developmental …
In January 2019, a study was published by the Journal of the Peripheral Nervous System on the design and characteristics of patient data collected from the Peripheral Neuropathy Research Registry (PNRR). This is the first ever overall study performed on this Patient Registry and one that truly highlights the importance of this dataset for current …
Key Data from FPN Patient Registry Highlighted in Top Medical Journal Read More »
NIH Award Will Support Research by Sandra Rieger, Ph.D., on Nerve Damage Induced by Cancer Chemotherapy BAR HARBOR, MAINE — The MDI Biological Laboratory has announced that Sandra Rieger, Ph.D., has been awarded a highly competitive grant from the National Cancer Institute, an institute of the National Institutes of Health (NIH), to study the molecular …
MDI Biological Laboratory Scientist Receives Grant to Study Peripheral Neuropathy Read More »
by Dr. Thomas Smith and Dr. Charles Loprinzi What is neuropathic pain, from the non-expert oncologist’s point of view? The way we think of it, pain is about the most protective instinct and impulse known to humans! If you touch a hot plate, you retract your hand even before you actually feel the pain. Then, the …
This past August, 2016, The National Institutes of Health (NIH) provided two separate grants supporting peripheral neuropathy research last month. This is excellent news as it demonstrates recognition of the need for funding in this area. MDI Biological Laboratory Conducting Peripheral Neuropathy Research The MDI Biological Laboratory has announced that it has received a grant …
NIH Provides Two Grants for Peripheral Neuropathy Research Read More »
Genetic Bio Marker may Predict Chemo-Induced Peripheral Neuropathy Side Effects Associated with Prostate Cancer Treatment New study finds genetic alterations in the VAC14 gene are associated with an increased risk of chemo-induced peripheral neuropathy in prostate cancer patients. Taxanes are a group of drugs commonly used to treat cancers of the breast, lung, ovary, or prostate, …
Chemo-Induced Peripheral Neuropathy may be Predicted by Genetic Bio Marker Read More »
